Silencing GCAT1 will promote the binding of PTBP1 to the IRES of CDKN1B mRNA, increase the level of p27 in GCs, inhibit cell cycle progression and proliferation of GCs, and lead to follicular atresia and ovarian insufficiency (Cho et al., 2005). The gene discussed is CDKN1B; the disease is ovarian dysfunction.